TY - JOUR
T1 - Neurodegenerative diseases
T2 - Neurotoxins as sufficient etiologic agents?
AU - Shaw, Christopher A.
AU - Höglinger, Günter U.
N1 - Funding Information:
Fig. 1 Schematic representation of different modes of putative gene-environment interactions in the etiology of a neurodegenerative disease ‘‘X’’, as defined by a unique clinical or neuropathological phenotype. (a) One of several genetic mutations may be the sole trigger the disease. (b) One of several environmental toxins may be the sole trigger of the disease. (c) One or several genetic mutations may be the prime trigger of the disease, the penetrance or severity of which may be modified by environmental factors. (d) One or several environmental toxins may be the prime trigger of the disease, the penetrance or severity of which may be modified by genetic factors. (e) Environmental and genetic factors, both being too weak individually to trigger the disease, may be required, interacting in a synergistic manner to trigger the disease Acknowledgments This work was supported by the US Army Medical Research and Materiel Command (#DAMD17-02-1-0678), Scottish Rite Charitable Foundation of Canada, and the Natural Science and Engineering Research Council of Canada (NSERC), and NINDS to CAS and European Union Grant LSHM-CT-2003-503330 to GUH. The authors thank Michael Petrik, Dr. Reyniel Cruz-Aguado and Dr. Denis Kay for helpful suggestions and commentary.
PY - 2008/3
Y1 - 2008/3
N2 - A dominant paradigm in neurological disease research is that the primary etiological factors for diseases such as Alzheimer's (AD), Parkinson's (PD), and amyotrophic lateral sclerosis (ALS) are genetic. Opposed to this perspective are the clear observations from epidemiology that purely genetic casual factors account for a relatively small fraction of all cases. Many who support a genetic etiology for neurological disease take the view that while the percentages may be relatively small, these numbers will rise in the future with the inevitable discoveries of additional genetic mutations. The follow up argument is that even if the last is not true, the events triggered by the aberrant genes identified so far will be shown to impact the same neuronal cell death pathways as those activated by environmental factors that trigger most sporadic disease cases. In this article we present a countervailing view that environmental neurotoxins may be the sole sufficient factor in at least three neurological disease clusters. For each, neurotoxins have been isolated and characterized that, at least in animal models, faithfully reproduce each disorder without the need for genetic co-factors. Based on these data, we will propose a set of principles that would enable any potential toxin to be evaluated as an etiological factor in a given neurodegenerative disease. Finally, we will attempt to put environmental toxins into the context of possible genetically-determined susceptibility.
AB - A dominant paradigm in neurological disease research is that the primary etiological factors for diseases such as Alzheimer's (AD), Parkinson's (PD), and amyotrophic lateral sclerosis (ALS) are genetic. Opposed to this perspective are the clear observations from epidemiology that purely genetic casual factors account for a relatively small fraction of all cases. Many who support a genetic etiology for neurological disease take the view that while the percentages may be relatively small, these numbers will rise in the future with the inevitable discoveries of additional genetic mutations. The follow up argument is that even if the last is not true, the events triggered by the aberrant genes identified so far will be shown to impact the same neuronal cell death pathways as those activated by environmental factors that trigger most sporadic disease cases. In this article we present a countervailing view that environmental neurotoxins may be the sole sufficient factor in at least three neurological disease clusters. For each, neurotoxins have been isolated and characterized that, at least in animal models, faithfully reproduce each disorder without the need for genetic co-factors. Based on these data, we will propose a set of principles that would enable any potential toxin to be evaluated as an etiological factor in a given neurodegenerative disease. Finally, we will attempt to put environmental toxins into the context of possible genetically-determined susceptibility.
KW - ALS
KW - Annonacin
KW - Atypical parkinsonism
KW - Cycad
KW - Environmental toxins
KW - Guadeloupe
KW - Guam
KW - MPTP
KW - Neurological disease cluster
KW - Parkinsonism-dementia complex
KW - Progressive subranuclear palsy
KW - Sterol glucosides
UR - https://www.scopus.com/pages/publications/49249112467
U2 - 10.1007/s12017-007-8016-8
DO - 10.1007/s12017-007-8016-8
M3 - Article
C2 - 17985252
AN - SCOPUS:49249112467
SN - 1535-1084
VL - 10
SP - 1
EP - 9
JO - NeuroMolecular Medicine
JF - NeuroMolecular Medicine
IS - 1
ER -